General Information of the Compound
| Compound ID |
CP0343999
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(3S,6S,14S)-6-acetamido-N-[(2S)-1-(1,3-benzothiazol-2-yl)-5-(diaminomethylideneamino)-1-oxopentan-2-yl]-3-benzyl-2,5,8-trioxo-1,4,9-triazacyclotetradecane-14-carboxamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C34H43N9O6S
|
||||||||||||||||||
| Molecular Weight |
705.842
|
||||||||||||||||||
| Canonical SMILES |
CC(=O)N[C@H]1CC(=O)NCCCC[C@H](NC(=O)[C@H](Cc2ccccc2)NC1=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)c1nc2ccccc2s1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C34H43N9O6S/c1-20(44)39-26-19-28(45)37-16-8-7-13-24(41-31(48)25(42-32(26)49)18-21-10-3-2-4-11-21)30(47)40-23(14-9-17-38-34(35)36)29(46)33-43-22-12-5-6-15-27(22)50-33/h2-6,10-12,15,23-26H,7-9,13-14,16-19H2,1H3,(H,37,45)(H,39,44)(H,40,47)(H,41,48)(H,42,49)(H4,35,36,38)/t23-,24-,25-,26-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
GEHOIKOYROYGLS-CQJMVLFOSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound